-
Biotech Industry Intelligence2 weeks ago
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
-
Biotech Industry Intelligence2 weeks ago
FDA posts photos of Indian drugmaking facility cited in warning letter
FDA posts photos of Indian drugmaking facility cited in warning letter
-
Biotech Industry Intelligence2 weeks ago
WuXi AppTec’s bet on the US pays off as revenues dip elsewhere
WuXi AppTec’s bet on the US pays off as revenues dip elsewhere
-
Biotech Industry Intelligence2 weeks ago
Former Acorda CEO Ron Cohen emerges at Parkinson’s cell therapy biotech Oryon
Former Acorda CEO Ron Cohen emerges at Parkinson’s cell therapy biotech Oryon
-
Biotech Industry Intelligence3 weeks ago
AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans
AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans
-
Biotech Industry Intelligence3 weeks ago
Collegium is acquiring Corium’s approved ADHD drug for $650M
Collegium is acquiring Corium's approved ADHD drug for $650M
-
Biotech Industry Intelligence3 weeks ago
Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win
Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win
Uncategorized30 minutes ago
STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more
Uncategorized2 hours ago
Pharma Pipeline Stalls for First Time in Decades: Citeline
Uncategorized2 hours ago
